NICE to work with NHS Race and Health Observatory to de-bias clinical guidance The two-year partnership will examine clinical guidance across maternal and neonatal health, mental health, genomics, sickle cell and hypertension.…
Monoclonal antibody ‘critical intervention’ for preventing infant RSV, study suggests Researchers found that nirsevimab reduced hospitalisations caused by respiratory syncytial virus in infants by more than 80%.…
Hub-and-spoke dispensing expansion set to begin in October 2025 Hub-and-spoke dispensing between different legal entities will be permitted from 1 October 2025 under draft amendments to the Human Medicines Regulations 2012.…
Medicines optimisation teams need to showcase their value to withstand ICB funding cuts With integrated care boards soon to have lost 65% of their funding over two years, now is the time for medicines optimisation teams to ‘be noisy’ about their work.…
Chief pharmacists call for medicines leadership to be ‘fundamental component’ of strategic commissioning system In a letter to NHS England, four integrated care board chief pharmacists said that they must shape and lead on medicines at a time of NHS change.…
PJ view: Strengthen the pharmacy frontline to secure the future of NHS healthcare This month, The Pharmaceutical Journal is launching a dedicated campaign aiming to champion solutions for the pharmacy workforce crisis.…
No increase in NHS prescription fees for the first time in three years The government has announced that the single item prescription charge for 2025/2026 will remain at £9.90.…
Ten ways to implement inclusive recruitment in pharmacy Tips and advice on how pharmacy teams can promote inclusivity throughout the recruitment process.…
NPA will not recommend collective action that could have limited pharmacy services The National Pharmacy Association has announced that it will not recommend collective action, following the new pharmacy contract.…
NICE reverses draft guidance to recommend targeted therapy for patients with advanced bowel cancer The National Institute for Health and Care Excellence said the treatment should be available on the NHS after the manufacturer provided additional clinical evidence.…
